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Brown adipose tissue is attracting much attention
due to its antiobestic effects; however, its develop-
ment and involvement in metabolic improvement
remain elusive. Here we established a method for
a high-efficiency (>90%) differentiation of human
pluripotent stem cells (hPSCs) into functional clas-
sical brown adipocytes (BAs) using specific hemo-
poietin cocktail (HC) without exogenous gene
transfer. BAs were not generated without HC, and
lack of a component of HC induced white adipo-
cyte (WA) marker expressions. hPSC-derived BA
(hPSCdBA) showed respiratory and thermogenic
activation by b-adrenergic receptor (AdrRb) stimuli
and augmented lipid and glucose tolerance,
whereas human multipotent stromal cell-derived
WA (hMSCdWA) improved lipid but inhibited glucose
metabolism. Cotransplantation of hPSCdBA nor-
malized hMSCdWA-induced glucose intolerance.
Surprisingly, hPSCdBAs expressed various hemo-
poietin genes, serving as stroma for myeloid progen-
itors. Moreover, AdrRb stimuli enhanced recovery
from chemotherapy-inducedmyelosuppression. Our
study enhances our understanding of BA, identifying
roles in metabolic and hemogenic regulation.
INTRODUCTION
Brown adipose tissue (BAT) is involved in nonshivering thermo-
genesis during cold exposure (Enerba¨ck et al., 1997) and
diet-induced thermogenesis (Feldmann et al., 2009). It also394 Cell Metabolism 16, 394–406, September 5, 2012 ª2012 Elseviecontributes to the prevention of aging-associated obesity, as
demonstrated in Ucp1 null mice (Kontani et al., 2005). In
large-sized mammals, the majority of BAT disappears within
a few days after birth; however, some portions remain and func-
tion through adulthood. 18Fluorodeoxyglucose-positron emis-
sion tomography in combination with computed tomography
(18F-FDG-PET/CT) along with histological and gene expressional
studies has shown the presence of functional BAT in adult
humans in supraclavicular and paravertebral regions (Cypess
et al., 2009; Virtanen et al., 2009; van Marken Lichtenbelt et al.,
2009; Saito et al., 2009; Yoneshiro et al., 2011). Although accu-
mulating evidence has shown an inverse correlation between
the amounts of active BAT and the development of metabolic
syndrome in humans (Ouellet et al., 2011; Jacene et al., 2011),
the cause-and-effect relationship between BAT and metabolic
improvement remains unsubstantiated. Moreover, the whole
picture of the development of human BAT is not clarified yet;
for example, it remains elusive whether BAT derives from
a common progenitor with myoblast, immature mesenchymal
cells from which white adipocyte (WA) is also generated or
from vascular components such as endothelial and perivascular
cells (Tran et al., 2012; Gupta et al., 2012), and whether bone
morphogenic protein 7 (BMP7) (Tseng et al., 2008) is sufficient
or additional cytokines are required for BA differentiation. The
newly proposed concept of brite adipocytes, WA-derived BA-
like cells (brown + white = brite) (Petrovic et al., 2010), makes
the situation complex, often encumbering an understanding of
classical BAT development. For an advanced understanding of
BAT, establishing a method to generate BAs from pluripotent
stem cells, including embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs), is of great use. Recently, a trial
to program human iPSCs (hiPSCs) into BA via transferring of
exogenous genes was reported (Ahfeldt et al., 2012); however,
biological effects of the programmed BA on lipid/glucosemetab-
olism remains unevaluated. Moreover, artificially programmedr Inc.
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mental pathways of human BA.
The existence of BAT in bone marrow (BM), which attenuates
with aging and diabetes, was reported in mice (Krings et al.,
2012). Also, a nontumorous infiltration of BAT in human BM
was reported in a case of essential hyperthrombocythemia
(Thorns et al., 2008). A functional link between BM fat and hema-
topoiesis was first reported by Dexter et al. (Dexter et al., 1977),
who showed that BM adipocytes with mitochondria-attached
multilocular lipid droplets were essential for the maintenance of
colony-forming units-spleen (CFU-S), a short-term repopulating
hematopoietic progenitor cell (HPC) distinct from hematopoietic
stem cell (HSC). Although the microenvironment for HSC (re-
viewed in Kiel and Morrison, 2006; Arai and Suda, 2007) and B
cells (Nagasawa, 2007) has been intensively studied, that for
myeloid progenitor cells (MPCs) remains poorly understood.
Moreover, controversial findings have been reported regarding
the effects of ‘‘BM adipocyte’’ on the committed HPCs: some
reports showed its capacity to support lymphopoiesis (Gimble
et al., 1990) and granulopoiesis (Gimble et al., 1992), while others
showed its inhibiting effects for hematopoiesis (Ookura et al.,
2007, Naveiras et al., 2009). The controversy may come from,
at least in part, the heterogeneity of bone marrow fat cells
including BAT versus white adipocyte tissue (WAT).
During our research into the feeder-free hematopoietic differ-
entiation of hPSCs, we serendipitously found the existence of
BA-like cell clusters surrounding the hematopoietic centers
and an induction of BA-selective gene, PRDM16 (see Figure S1
online). Because the hematopoietic differentiation was achieved
under a completely feeder-free condition, a de novo hematopoi-
etic stroma must be generated from hPSCs per se. Eventually,
murine C3H10T1/2 line, a commonly used feeder for the hema-
topoietic differentiation of monkey (Hiroyama et al., 2006) and
human (Takayama et al., 2008) ESCs, can differentiate into func-
tional BA (Tseng et al., 2008). Thus, an association between BA
development and hemopoiesis has been suggested.
After a process of trial and error, we established a high-effi-
ciency method to produce functional BAs from hPSCs including
human ESCs (hESCs) and hiPSCs. Involvement of hPSC-derived
BAs (hPSCdBAs) in metabolic improvement, its service as
a stroma for MPCs, and the existence of BA in vertebral BM
are also shown.
RESULTS
Directed Differentiation of Human PSC into
Functional BA
By utilizing a specific hemopoietin cocktail (HC) composed of
KIT ligand (KITLG), fms-related tyrosine kinase 3 ligand
(FLT3LG), interleukin-6 (IL-6), and vascular endothelial growth
factor (VEGF) along with the previously reported BA inducer
BMP7 (Tseng et al., 2008), we successfully established a highly
efficient BA differentiation method for hESCs and hiPSCs
(Supplemental Information). The differentiated cells exclusively
contained multilocular lipid droplets (Figure 1A), as confirmed
by oil red O staining (Figure 1B). Quantitative RT-PCR studies
demonstrated the induction of BAT-specific genes of UCP1
and PRDM16, which were not detected in human multipoint
stromal cell-derived WA (hMSCdWA) (Figure 1C). AlthoughCell Medepletion of BMP7 significantly lowered BA differentiation effi-
ciency as reported by Tseng et al. (Tseng et al., 2008) (Figure S2),
BA differentiation was completely abolished by HC depletion
even in the presence of BMP7 (Figure 1D). Expression of a series
of BAT-selective and BAT/WAT-common genes, but not WAT-
selective genes, was also determined (Figure 1E). UCP1 protein
expression was confirmed by immunostaining studies, showing
that over 95% of the BA differentiated cells expressed UCP1 at
mitochondria (Figure 2A), and also western blotting, showing the
presence of a 32 kDa band in the differentiated cells (Figure 2B).
Lipid staining illustrated the wide distribution of mitochondria
within the cytosol, some of which resided close to lipid droplets
(Figure 2C). Electron micrographs confirmed the presence of
multilocular lipid droplets and abundant mitochondria rich in
transverse cristae (Figure 2D and Figure S3A), some of which
located in close vicinity to lipid droplets (Figure S3B), in contrast
to hMSCdWA, which showed meager mitochondria
(Figure S3C).
We next evaluated the functional maturation of hESC/hiPSC-
derived BAs. First, thermogenic potential was evaluated. Treat-
ment with a b-adrenergic receptor, isoproterenol, augmented
the expression of UCP1, a major contributor to thermogenesis,
and PRDM16, a major inducer of UCP1 expression, in
hPSCdBAs (Figures 3A and 3B, left). Isoproterenol-responsive
thermogenic activation (Jackson et al., 2001) was further
confirmed in vivo by subcutaneous transplantation of
hPSCdBAs into mice (Figures 3A and 3B, right). Respiratory acti-
vation was also assessed in vitro: hPSCdBAs showed consider-
ably higher basal and maximum OCRs than hMSCdWA as
demonstrated by a standard Mito Stress Test (Figure 3C).
Responsiveness to a b3-adrenergic receptor-selective agonist,
CL316,243, was also determined: statistically significant upregu-
lation in oxygen consumption rates (OCRs) was determined in
the cases of hPSCdBAs in response to CL316,243, whereas
no significant changes were observed in the cases of hMSCdWA
and immature hPSCs (Figure 3D). Upregulation of OCR was
further determined in isoproterenol-treated hPSCdBAs (data
not shown).
Together, these findings support the production of functional
BAs from hPSCs.
Effects of hPSC-Derived BA on Lipid and Glucose
Metabolism
Because endogenous BAT reportedly reduces blood triglyceride
(TG) levels in response to cold stimuli (Bartelt et al., 2011), we
examined the effects of transplantation of hPSCdBA on lipid
metabolism. Compared to immature hPSC-transplanted mice,
hPSCdBA-transplanted mice (Figure 4A, middle column) and
hMSCdWA-transplanted mice (Figure 4A, right column) showed
reduced fasting TG levels. Olive oil tolerance tests further
confirmed that hPSCdBA transplantation augmented resistance
to oral lipid loading (Figure 4B).
Next, effects of hPSCdBAs on glucose metabolism were eval-
uated. Ten-week-old mice were subcutaneously injected with
saline, hESC-derived BA (hESCdBA), or hMSCdWA, and blood
glucose levels were measured over time (Figure 4C). Fasting
blood glucose levels were significantly lowered in hESCdBA-
transplanted mice compared to saline-injected mice (p =
0.0032; n = 3) and to hMSCdWA-transplanted mice (p = 0.0030;tabolism 16, 394–406, September 5, 2012 ª2012 Elsevier Inc. 395
Figure 1. Differentiation of hPSCs into BAs
(A) Microscopy of hPSC-derived cells. Scale bar, 50 mm.
(B) Oil red O staining (right) with phase contrast microscopy (left). Scale bar, 40 mm.
(C) Expression of PRDM16 and UCP1 determined by RT-PCR (left) or real-time PCR (middle and right). The error bars represent average ± standard deviation
(SD) (n = 3).
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Figure 2. Analyses on Protein Expressions
and Fine Structures
(A) Immunostaining using an anti-UCP1 and anti-
SOD2 antibody as indicated. Scale bar, 50 mm.
(B) Western blotting using an anti-UCP1 as indi-
cated.
(C) Lipid staining. hESC-derived differentiated
cells were stained by an anti-UCP1 antibody (red)
and BODIPY 493/503 (green). Scale bar, 5 mm.
(D) EM of hiPSC-derived cells (left) and hESC-
derived cells (right). L, lipid droplets; M, mito-
chondria. Scale bar, 2 mm.
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showed elevated homeostasis model assessment-insulin resis-
tance (HOMA-IR) values compared not only with hESCdBA-
transplantedmice (p = 0.0003; n = 3) but also with saline-injected
mice (p = 0.0011; n = 3) (Figure 4E), indicating that hMSCdWA
induces insulin resistance despite its favorable effect on lipid
metabolism. Similar results were obtained when 6-week-old
youngermicewereused for theassay (data not shown). As shown
in Figure 4F, oral glucose tolerance tests (OGTTs) further
demonstrated that hESCdBA transplantation reduced 15 min
blood glucose values compared to saline injected (p = 0.010;
n = 3), while hMSCdWA-transplanted mice exhibited elevated
30 min blood glucose values compared not only with
hESCdBA-transplanted mice (p = 0.0034; n = 3) but also with
saline-injected mice (p = 0.0055; n = 3). Similar results were ob-
tained when 6-week-old younger mice were used for the assay(D) BA differentiation in the presence or absence of HC.Microscopy (upper) and expressions ofPRDM16 (lowe
shown. Scale bar, 50 mm. The error bars represent average ± SD (n = 3).
(E) Expression of BAT-selective, BAT/WAT-common, and WAT-selective genes examined by RT-PCR.
hMSCdWA.
Cell Metabolism 16, 394–406, S(data not shown), confirming that
hMSCdWA transplantation deteriorates
glucose metabolism. The different effects
between hESCdBA and hMSCdWA were
not due to the difference in cell survival,
as we clearly detected the existence of
transplantedcells (FigureS4A).Moreover,
deterioration of glucose metabolism by
hMSCdWA transplantation could not
be attributed to inflammation, because
we did not observe any signs of inflam-
mation, such as macrophage infiltration
(Figure S4B). In addition, hMSCdWA
did not express tumor necrosis factor
a (TNFA), and it expressed only a low level
of lL1B (Figure S4C).
We also examined longer-term effects
of hPSCdBA transplantation using immu-
nocompromised NOG mice (Ito et al.,
2002). Fasting blood glucose level-
lowering effects of hESCdBA were deter-
mined at least for 3 weeks (Figure 4G).
Cells with multilocular lipid droplet (Fig-
ure 4H) that expressed UCP1 (Figure 4I)and human HLA-A,B,C (Figure 4J) were determined by histolog-
ical analyses. Around the graft tissue, microvasculatures were
also detected (Figure 4H arrowheads).
Finally, we assessed possible therapeutic effect of hESCdBA
on hMSCdWA-induced deterioration of glucose metabolism.
Although no significant changes in fasting blood glucose values
and HOMA-IR values were observed (Figure 4K and 4L),
cotransplantation of an equivalent number of hESCdBA
ameliorated the deleterious effect of hMSCdWA, significantly
lowering the 30 min blood glucose values (p = 0.0014; n = 3)
(Figure 4M).
All those findings together indicate that (1) hPSCdBAs
improve both lipid and glucose metabolism, (2) hMSCdWA
improved lipid but deteriorates glucose metabolism, and (3)
hPSCdBAs ameliorate adverse effects of hMSCdWA on
glucose metabolism.r left) andUCP-1 (lower right) by real time PCRwere
I, immature hPSC; D, differentiated hPSC; WA,
eptember 5, 2012 ª2012 Elsevier Inc. 397
Figure 3. Thermogenic and Mitochondrial
Respiratory Activation
(A and B) Thermogenesis studies. hESCdBA (A)
and hiPSCdBA (B) were treated with isoproterenol.
Gene expression was examined by RT-PCR over
time (A, left; B, left). Thermographic images of mice
transplanted with saline, immature hESC (ihESC),
hESCdBA, immature hiPSC (ihiPSC), or hiPSCdBA
before and after isoproterenol treatments are
shown (A, right; B, right). Arrows indicate regions
of transplantation; arrowheads indicate areas of
endogenous murine BAT.
(C) Mito stress tests were performed using
hESCdBA, hiPSCdBA, and hMSCdWA as indi-
cated.
(D) OCR was measured in hESCdBA, hiPSCdBA,
hMSCdWA, immature hESCs, and immature
hiPSCs after a 4 hr incubation with or without
CL316,243. The error bars in (C) and (D) represent
average ± SD (n = 3).
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To confirm that our differentiation technique correctly repro-
duced classical BAT development via myoblastic differentiation
(Timmons et al., 2007; Seale et al., 2008; Sun et al., 2011), the
expression of a series of developmental markers was examined.
As shown in Figure 5A, myoblastic MYF5 expression was tran-
siently upregulated during the initial floating culture step of
differentiation. Moreover, the expression of a paraxial mesoderm
marker, platelet-derived growth factor receptor a (PDGFRA)
(Sakurai et al., 2006), was upregulated. By contrast, the levels
of immature mesenchymal stem cell marker, NG2 and PDGFRB
(Crisan et al., 2008), as well as a lateral plate mesoderm marker,
VEGFR2 (Sakurai et al., 2006), were reduced. The precedence of
myoblastic differentiation was further confirmed by the transient
induction of PAX3/7, which are involved in myogenic commit-398 Cell Metabolism 16, 394–406, September 5, 2012 ª2012 Elsevier Inc.ment (Figure 5B). Thus, our method
correctly mimics the classical BAT
development but not a brite adipocyte
pathway via immature mesenchymal
stem cell differentiation.
We further evaluated the detailed role
of each hematopoietin. The absence of
any one of the components of HC low-
ered the quality of BA differentiation,
reducing cellular viability and/or percent-
ages of multilocular lipid-containing cells
(Figure 5C). Gene expression studies
further showed that VEGF was required
for PRDM16 expression, whereas KITLG,
IL6, or FLT3LG was required for sub-
sequent UCP1 expression (Figure 5D).
Surprisingly, depletion of either KITLG,
IL6, or FLT3LG paradoxically induced
the expression of a WAT marker, phos-
phoserine aminotransferase 1 (PSAT1)
(Seale et al., 2007), and a lateral plate
mesoderm marker, vegfr2. Thus, the
HC is essential for the differentiation ofhPSCs into classical BA, and the omission of any of the HC
components results in WAT lineage commitment.
We also examined intracellular signaling by performing inhib-
itor analyses. Because a BMPR1a inhibitor (BMPR1a-i) and
p38 MAPK inhibitor (p38-i) reportedly hamper BA differentiation
(Sellayah et al., 2011), effects of these two inhibitors, along with
those of a MAP kinase-ERK kinase (MEK) inhibitor (MEK-i), were
examined. We found that BMPR1a-i induced massive cell death
during the floating culture step of BA differentiation (Figure 5E,
second left). Cell death had been induced as early as day 1
(data not shown). Similar results were obtained from the case
of AKT inhibitor (AKT-i). (Figure 5E, right). Thus, BMPR1a-
dependent signaling is required for the survival of immature
sphere-forming progenitor cells, from which mature BA will be
produced. We then followed up the p38-i- and MEK-i-treated
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of hESC, p38-i treatment reduced the number of lipid droplet-
containing cells (Figure 5F, upper middle), while MEK-i treatment
exerted minimal effects (Figure 5F, upper right). Compatible to
these morphological findings, p38-i treatment, but not MEK-i
treatment, lowered PRDM16 and UCP1 expression levels (Fig-
ure 5G, left half). By contrast, p38-i treatment exerted minimal
effects on hiPSCs (Figure 5F, lower middle), whereas MEK-i
treatment induced cogeneration of the cells with unilocular lipid
droplets (Figure 5F, lower right). Compatibly, PRDM16 and
UCP1 expressions were only slightly reduced in p38-i-treated
hiPSCs but clearly reduced in MEK-treated hiPSCs (Figure 5G,
right half). Therefore, p38 MAPK and ERK signaling play impor-
tant roles in BA differentiation depending on the lines or kinds
of hPSCs.
A Functional Link between BA and Hematopoiesis
There has been a controversy regarding the effect of BM
adipocytes on the proliferation and differentiation of committed
HPCs. For example, murine BM adipocytic lines are reportedly
capable of supporting lymphopoiesis (Gimble et al., 1990) and
granulopoiesis (Gimble et al., 1992), whereas humanBM-derived
fat cells generated by a dexamethasone/insulin treatment
reduce colony-forming capacities of HPCs (Ookura et al.,
2007). We hypothesized that the controversy came from the
heterogeneity of BM adipocytes and that BA, but not WA, serves
as a stroma for committed HPCs for the following reasons: (1)
hematopoietic stromal cells essential for maintaining CFU-S
exhibit morphological resemblance to BA rather than to WA
(Dexter et al., 1977); (2) the murine embryo-derived C3H10T1/2
cell line (Reznikoff et al., 1973), which differentiates into mature
BAT on BMP7 treatment (Tseng et al., 2008), is widely used as
a feeder for the hematopoietic differentiation of monkey (Hir-
oyama et al., 2006) and human (Takayama et al., 2008) ESCs;
(3) BM is replaced by WA in severe myelosuppressive states
including aplastic anemia; and (4) treatment with dexametha-
sone/insulin induces differentiation into WA but not BA.
To validate our hypothesis, human umbilical cord blood
CD34+ HPCs were cultured on hESCdBA layers for 1 week in
the absence of any recombinant hematopoietic cytokines.
Then, floating cells were subjected to intrabone marrow trans-
plantation (IBM-T) into alymphocytic NOG mice, and after
8 weeks, splenic chimerisms were measured to assess the
expansion of CFU-S. For a control, CD34+ cells were directly
transplanted without culturing on hPSCdBA layers (Figure 6A).
As shown in Figure 6B, splenic chimerisms were significantly
higher in hPSCdBA-cocultured CD34+-transplanted mice than
in mice with direct transplantation (p = 0.041; n = 3). Moreover,
percentages of human CD33-positive myeloid cells were larger
in cocultured CD34+-transplanted mice (4.8 ± 0.13 versus
3.0 ± 0.19; p = 0.00022; n = 3, data not shown), while no signif-
icant changes in B lymphocyte percentages were observed
(data not shown). These findings indicate that hPSCdBA serves
as a stroma for MPCs, promoting their expansion/differentiation
and homing to the spleen.
We also examined the expression of hematopoietic cytokines
involved in the expansion and differentiation of committed
HPCs. Various hematopoietin genes including thrombopoietin
(THPO), IL6, IL3, colony-stimulating factor 3 (CSF3), colony-Cell Mestimulating factor 2 (CSF2), and erythropoietin (EPO) were ex-
pressed in hESCdBA (Figure 6C, middle lanes) and hiPSCdWA
(data not shown). On the other hand, hMSCdWAs expressed
only IL6 among these hemopoietins (Figure 6C, right lanes).
Moreover, the expression levels of the hematopoietin genes in
hESCdBA (Figure 6D) and hiPSCdBA (data not shown) were
upregulated by isoproterenol treatments, further supporting the
notion that hPSCdBA serves as stromal for committed HPCs.
To evaluate in vivo relevance, we examined whether isoproter-
enol treatment could enhance the recovery from antitumor
agent-induced myelosuppression by enhancing the expansion/
differentiation of MPCs. Mice were treated with 5-fluorouracile
(5-FU), and bone marrow cells were collected and analyzed
over time (Figure 6E). As reported by Hofer et al. (Hofer et al.,
2007), 5-FU-treated mice were at the nadir at day 3, when
a decline in total enucleated cell number (11.33 ± 1.74 versus
4.87 ± 0.96 [3106], p = 0.0023; n = 3) (Figure 6F) as well as
a reduction in early myeloid cells (Figures S5A–S5C) were
observed. Although total cell number (8.70 ± 0.40; n = 3) (Fig-
ure 6F) and the percentages of R1 fraction (Figures S5A and
S5B) were eventually upregulated at day 7 as a sign of a recovery
frommyelosuppression, themice still suffered from a shortage of
mature myeloid cells (Figures S5A–S5C). By contrast, isoproter-
enol-treated mice showed higher enucleated cell number
(10.93 ± 1.14, p = 0.032; n = 3) (Figure 6F) with significantly larger
R2 fraction percentages (Figures S5A and S5B). Cytological
studies confirmed all those findings (Figure S5C).
The existence of BA in BM has long been suggested despite
the lack of direct evidence (reviewed in Motyl and Rosen,
2011). A relationship between osteoblast and BA was reported
in mice (Calo et al., 2010). Moreover, murine BM fat reportedly
expresses various BA-selective messages (Krings et al., 2012).
To assess the possible existence of BA in human BM, expres-
sions of BAT-specific markers,UCP1 and PRDM16, were exam-
ined using commercially available human BM RNA samples.
As shown in Figure 7A, expression of both genes was detected
by RT-PCR, whereas they were undetectable in human BM-
originated MSC-derived WA (hBM-MSCdWA). To further assess
the existence of active BM-BAT in vivo, 18F-FDG-PET/CT
examinations were performed in healthy young volunteers
(24.8 ± 5.8 of age; n = 20) with or without cold stimuli (Saito
et al., 2009; Yoneshiro et al., 2011).We identified cold-stimulated
18F-FDG uptake in vertebral BM (Figures 7B–7D), whose signal
intensities showed an intimate correlation with those of BATs
(p < 0.001), but not of those of brain, heart, spleen, or muscle
(Figures S6A and S6B). The presence of vertebral BM was
histologically examined using 3-week-old murine vertebral BM
samples: we successfully detected the cells with BA morphol-
ogies (Figure 7E) that were positive for UCP1 protein expression
(Figure 7F). Collectively, those findings strongly suggest the
presence of functional BA in the BM of vertebrae.
DISCUSSION
We established a highly efficient method for the differentiation
of hPSCs into functional BAs. This is the first success in gener-
ating functional classical BA pluripotent stem cells without
exogenous gene transfer. By virtue of its technological merits,
ourmethod provides a valuable tool for BAT research. Functionaltabolism 16, 394–406, September 5, 2012 ª2012 Elsevier Inc. 399
Figure 4. Metabolic Improvement by hPSC-Derived BA Transplantation
(A) Blood TG clearance tests. Immunocompetent ICR mice were transplanted with immature hESCs (ihESC) (n = 3 mice), hESCdBA (n = 3 mice), or hMSCdWA
(n = 3 mice). After 16 hr starvation, isoproterenol was administrated and blood TG levels were measured.
(B) Oral fat tolerance tests. ICRmice were transplanted with immature hiPSC (ihiPSC) (n = 3mice) or hiPSCdBA (n = 3mice). Olive oil was orally loaded, and blood
TG levels were measured over time after isoproterenol treatments.
(C–F) OGTT. ICR mice were injected with saline (n = 3 mice), hESCdBA (n = 3 mice), or hMSCdWA (n = 3 mice), and OGTT was performed (C). Fasting blood
glucose levels (D), HOMA-IR (E), and blood glucose values after oral glucose loading (F) are shown.
(G–J) Immunocompromized NOG mice were injected with saline or transplanted with hESCdBA. At indicated time points, fasting blood glucose levels
were measured. Three mice (day 10) or five mice (Day 21) were used for each condition (G). Histological studies were performed by HE staining (H) and
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has also been generated from human multipotent adipose-
derived stem cells by chronic treatment with thiazolidinediones
(Elabd et al., 2009). The merit of our system is that it does not
require preparation of human specimen materials but utilizes
hPSCs, which are capable of unlimited expansion in vitro.
One of the main findings of our research is that HC composed
of KITLG, IL6, FLT3LG, and VEGF is essential for BA differentia-
tion of hPSCs. Although BMP7 plays an important role in BA
differentiation of hPSC (Figure S2) as reported in murine cases
(Tseng et al., 2008), HC is indispensable for BA differentiation
of hPSCs (Figure 1D). It is known that VEGF is synthesized in
rodent BAT (Asano et al., 1997; Tonello et al., 1999), promoting
the angiogenesis within BAT. Moreover, IL6 is reportedly
secreted from cultured human BM adipocytes (Laharrague
et al., 2000). Our findings imply that VEGF and IL6, together
with KITLG and FLT3LG, work as fundamental autocrine or
paracrine factors to promote BA differentiation.
Compatible to the finding by Sellayah et al. (Sellayah et al.,
2011), the inhibitor analyses demonstrated the involvement of
p38 MAPK signaling, but not of MEK signaling, in BA differen-
tiation of hESC (Figures 5E–5G). However, distinct findings
were obtained from the case of hiPSCs, in which MEK
signaling played a role in BA differentiation (Figure 5E–5G). At
this moment, the basis for the difference in the effects of iden-
tical inhibitors between hESCs and hiPSCs remains elusive. It
may be related to the difference in the genetic background
of pluripotent stem cell lines, reflecting the individual difference
of the ‘‘donor’’ or the difference in the type of pluripotent stem
cells or both. Further investigations are required to obtain the
whole picture of the molecular basis for BA differentiation of
hPSCs.
By providing high-purity human BA and WA materials, we
demonstrated the differential effects on metabolic regulation
between BA and WA: BA improves while WA deteriorates
glucose metabolism. Because those effects were confirmed
by a short-term assay without body weight changes and also
because the effects of BA and WA on lipid metabolism were
similar, the beneficial effect of BA on glucose metabolism is
not a secondary consequence of general metabolic improve-
ment. Conventional subcutaneous fat transplantation experi-
ments were not able to distinguish the effect of BA from that of
WA, because subcutaneous fat tissues contain both WA and
BA. Thus, our system will provide a unique tool for the research
of BA in regard to glucose metabolism.
Another surprising finding is the functional link between BA
and hematopoiesis. We showed that hPSCdBAs serve as
a stroma for MPCs. In contrast to the ‘‘niche’’ for HSCs, which
is composed of immature osteoblasts and sinusoidal endothelial
cells, the ‘‘stroma’’ for committed HPCs remains a mystery. The
only report showing the characteristic of such stroma was
a study by Dexter et al. (Dexter et al., 1977), in which BM fat cells
with multilocular lipid droplets attached by mitochondria
were identified as a stroma for CFU-S. Our results indicatingimmunostaining using an anti-UCP1 antibody (I) and anti-human HLA-A,B,C ant
50 mm.
(K–M) Mice were transplanted with hMSCdWAs alone or together with hESCdB
and blood glucose values after oral glucose loading (M) are shown. The error ba
Cell Methat (1) hPSCdBAs express various hematopoietic cytokines in
response to b-adrenergic receptor stimuli, (2) hPSCdBAs
promote myelopoiesis of human cord blood CD34+ cells, and
(3) b-adrenergic receptor stimuli accelerate the recovery from
5-FU-mediated myelosuppression together show that BM-BAT
serves as a stroma for MPCs. Among those, the third finding is
particularly important because it illustrates a very feasible way
to shorten the period of myelosuppression, the major side effect
of intensive chemotherapy for progressive cancers.
The PET-CT results of young healthy volunteers, together
with gene expression analyses of human BM specimen and
histological examinations of murine vertebral BM samples,
strongly suggest the existence of active BAT in vertebral BM in
mammals. Because classical BAT is derived fromMyf5-positive
myoblastic cells (Seale et al., 2008) and because Myf5-positive
cells emerge at the juxtaspinal, prospectively paravertebral,
regions within somites (Cossu et al., 1996; Braun and Arnold,
1996), the existence of BA in vertebral BM seems reasonable.
Because the major portions of vertebrae are composed of
trabecular bones, which are the sites of active hematopoiesis,
and the vertebral marrow is the last reserve site for hematopoi-
etic activity in aged individuals (Tanaka and Inoue, 1976), the
hematopoietic microenvironment of vertebral BM may bear
a unique character. Further investigation will elucidate the whole
picture of HPC regulation.
Our system, providing highly functional hiPSCdBA, may open
a new avenue to the therapy for obesity. However, we have
found that BA differentiation efficiencies substantially differ
among hiPSC lines (data not shown), as reported in the case of
pancreatic b cell differentiation of hESCs (Osafune et al., 2008).
For clinical application, selection of appropriate lines of hiPSCs
will be as important as sophisticating the whole differentiation
process into good manufacturing practice levels.
EXPERIMENTAL PROCEDURES
Establishment of hiPSCs and Provision of hESCs
SeV-iPS cells were established from human neonatal fibroblast or human
umbilical vein endothelial cells by introducing Yamanaka’s four factors using
CytoTune-iPS ver.1.0 (DNAVECCorp) (Figure S7). Transgeneswere eliminated
by a 395C heat treatment for 5 days. A hESC line (KhES-3) was generously
provided by the Institute for Frontier Medical Science, Kyoto University
(Suemori et al., 2006).
A Directed Differentiation of hESCs/hiPSCs into Functional BA
hESCs or hiPSCs were cultured in a 6 cm low-attachment culture dish using
a serum-free differentiation medium composed of 1:1 ratio of IMDM (I3390,
Sigma Chemical Co.) and Ham’s F12 (087-08335, WAKO Pure Chemical
Industries), 5 mg/ml bovine serum albumin (A802, Sigma Chemical Co.),
1:100 synthetic lipids (GIBCO #11905-031, Life Technologies, Inc.), 450 mM
a- monothioglycerol (207-09232, WAKO Pure Chemical Industries), 1:100
insulin-transferrin-selenium (ITS-A, Life Technologies, Inc.), 2 mM Glutamax
II (GIBCO #35050-061, Life Technologies, Inc.), 5% protein-free hybridoma
mix (PFHMII, GIBCO #12040-077, Life Technologies, Inc.), 50 mg/ml
ascorbic acid-2-phosphate (Sigma, A-8960), and the hematopoietic cytokine
cocktail I (5 ng/ml IGF-II, 20 ng/ml BMP4, 5 ng/ml VEGFA, 20 ng/ml
KITLG, 2.5 ng/ml FLT3LG, 2.5 ng/ml IL-6) for 8 days to form spheres. Theibody (J) at day 7. Arrowheads in (H) indicate microvasculatures. Scale bars,
A, and OGTT was performed. Fasting blood glucose levels (K), HOMA-IR (L),
rs in (A), (B), (D)–(G), (K), (L), and (M) represent average ± SD.
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Figure 5. Signals Involved in BA Differentiation
(A) Developmental marker expression was examined by RT-PCR during BA differentiation of hESCs. Similar results were obtained regarding hiPSCs
(data not shown).
(B) Myoblastic marker expressions were determined by RT-PCR during floating culture.
(C and D) The role of each cytokine was evaluated by morphological examinations (C) and RT-PCR (D). Scale bar, 100 mm (upper panels); and scale bar, 150 mm
(lower panels).
(E–G) Inhibitor analyses. BA differentiation was performed in the presence of inhibitors of BMPR1a, p38 MAPK, MEK1, or AKT as indicated. Phase contrast
micrographs of the spheres at day 8 (scale bar, 200 mm) (E) and those of BA at day 10 (scale bar, 50 mm) (F) were shown. Expressions ofUCP1 and PRDM16were
determined at day 10 by RT-PCR (G).
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Figure 6. Hematopoietic Stromal Assays
(A) Schematic presentation of the assay.
(B) After 8 weeks from transplantation, cells were collected from the spleen and subjected to flow cytometry. hCD45-positive percentages were calculated.
Similar results were obtained at 6 and 12 weeks after transplantation (data not shown). The error bars represent average ± SD (n = 3).
(C and D) Various hematopoietin expressionwas examined by RT-PCR in immature hESCs (ihESCs), hESCdBAs, and hMSCdWAs (C). Hematopoietin expression
in hESCdBAs after isoproterenol treatments was examined over time by RT-PCR (D).
(E and F) 5-FU treatment assay. Experimental procedure (E) and the results of BM-enucleated cell counts (F) were shown. The error bars represent average ± SD
(n = 3).
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plates using the above-described serum-free medium supplemented
with the hematopoietic cytokine cocktail II (5 ng/ml IGF-II, 10 ng/ml BMP7,
5 ng/ml VEGFA, 20 ng/ml KITLG, 2.5 ng/ml FLT3LG, 2.5 ng/ml IL-6) for
several days.
Protein Expression Analyses
Immunostaining was performed using a goat polyclonal anti-human UCP1
antibody (sc-6528, Santa Cruz Biotechnology, Inc.) or a rabbit polyclonal
anti-human SOD2 antibody LS-C39331, LifeSpan BioSciences Inc., Seattle,
WA) as described previously (Nakahara et al., 2009). Western blotting was
performed using a rabbit polyclonal UCP1 (Ab10983) (Abcam plc., Cambridge,
UK) as described previously (Nakahara et al., 2009).
Gene Expression Analyses
RT-PCRwas performed using primers described in Supplemental Information.
Quantitative RT-PCR (qPCR) was performed by applying SYBR Green qPCRCell Memethod using primers purchased from SuperArray (QIAGEN Science,
Maryland, USA) as described in the Supplemental Experimental Procedures.
The results were normalized by GAPDH.
Electron Microscopic Examinations
Cells were fixed by 2.5% glutaraldehyde. Postfixation by 2% osmium
tetroxide, along with sample embedding into resin and slicing, was
performed by Bio Medical Laboratories Co. Ltd. (Tokyo, Japan) (Saeki et al.,
2000).
Inhibitor Analyses
BA differentiation was performed by adding the following inhibitors to
the differentiation medium: 10 mM p38 MAP kinase inhibitor (Cat 506126)
(Calbiochem Co., Darmstadt, Germany), 50 mM MEK1 inhibitor (PD 98059)
(Calbiochem Co.), 10 mM BMPR1a inhibitor (Dorsomorphin Dihydrochloride,
Cat 047-31801) (WAKO Pure Chemical Industries, Osaka, Japan), and
10 mM Akt inhibitor IV (Cat 124011) (Calbiochem Co.).tabolism 16, 394–406, September 5, 2012 ª2012 Elsevier Inc. 403
Figure 7. Examinations on BM-BAT
(A) Expression of PRDM16 and UCP1 in BM
RNA samples of 27-year-old and 41-year-old
males and human BM-derived hMSCdWA (hBM-
MCdWA).
(B) 18F-FDG-PET/CT. Typical results of the
frontal images under warm and cold conditions
were shown. Arrows indicate 18F-FDG uptake
into vertebrae per se, and arrowheads indicate
18F-FDG uptake into classical paravertebral BA.
(C and D) Shown are sagittal and axial section
images of 18F-FDG-PET/CT under warm (C) and
cold conditions (D). Arrows indicate the 18F-FDG
uptake into vertebral BM.
(E and F) Thoracic vertebra of 3-week-old ICR
mice was subjected to HE staining (E) or UCP1
immunostaining (FF). Arrowheads indicate the
existence of BA.
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The adherent culture step of BA differentiation was performed on special
96-well plates (Seahorse Bioscience Inc., Billerica, MA) precoated by 0.1%
gelatin by seeding 30 spheres per well. Oxygen consumption was analyzed
by Extracellular Flux Analyzer XF96 (Seahorse Bioscience Inc.) according to
the manufacturer’s guidance.
Calorigenic Analyses
The 13 106 of hPSCdBA or immature hPSCs were suspended in 100 ml saline
and subcutaneously transplanted into 5-week-old male ICR mice After 24 hr,
30 mmol/kg of isoproterenol (12760, Sigma Chemical Co.) was administrated
from the tail vein. After another 4 hr, mice were anesthetized, and dermal
temperature was measured by Thermo GEAR G120/G100 (NEC Avio Infrared
Technologies Co., Ltd, Tokyo, Japan). All animal care procedures involved in
calorigenic analyses, assessment of lipid and metabolism, and hematopoietic
stromal assays were approved by the Animal Care and Use Committee of
the Research Institute, National Center for Global Health and Medicine
(NCGM), and complied with the procedures of the Guide for the Care and
Use of Laboratory Animals of NCGM.
Assessment of Lipid Metabolism
Six-week-old male CRmice were subcutaneously transplanted with 13 106 of
immature hESC, hESCdBA, or hMC-derivedWAsuspended in 100ml saline and
kept abstained from feed. After 16 hr, isoproterenol (30 mmol/kg) was adminis-
trated. After another 2 hr, blood samples were taken, and TG concentrations404 Cell Metabolism 16, 394–406, September 5, 2012 ª2012 Elsevier Inc.were measured by Accutrend Plus (F. Hoffmann-
La Roche, Ltd., Basel, Switzerland). For oral fat
tolerance tests, ICR mice were subcutaneously
transplanted with immature hPSC or hPSCdBA
and kept abstained from feed. After 16 hr, isopro-
terenol (15 mmol/kg) was administrated. After
another 2 hr, 200 ml of olive oil was orally adminis-
trated, and blood TG levels were measured
every 2 hr.
Assessment of Glucose Metabolism
The 13 106 of hESCdBA or hMSCdWAwas trans-
planted to 6- or 10-week-oldmale ICRmice, which
were kept abstained from feed. After 16 hr, isopro-
terenol (30 mmol/kg) was administrated. After
another 4 hr, 2 g/kg of glucose (041-00595, Wako
Pure Chemical Industries, Ltd., Osaka, Japan)
wasorally administrated.Blood samplewere taken
after 0, 15, 30, and 60min. Blood glucose concen-
trations were measured by Accutrend Plus, and
plasma insulin concentrations were measuredby mouse insulin ELISA kit (Morinaga Institute of Biological Science, Inc.,
Yokohama, Japan).
Hematopoietic Stromal Assays
The human cord blood CD34+ cells were cultured on hPSCdBA layers without
recombinant cytokines in RPMI1640 medium supplemented with 10% fetal
calf serum. Floating cells were collected after 7 days, and 2 3 105 cells were
transplanted into tibial bone marrow of NOG mice. After 6, 8, and 12 weeks,
cells were collected from contralateral femoral bone marrow and spleen and
subjected to cytometry using an anti-human CD45-FITC (clone J33) (Beckman
Coulter Inc.) and anti-human CD33-PE antibody (clone WM53) (BD Biosci-
ences, San Jose, CA). For control, cord blood CD34+ cells were directly trans-
planted without coculture. For myelosuppression recovery assays, 100 mg/kg
of 5-FUwas intraperitoneally administrated. Fromday 3 to day 6, 30 mmol/kg of
isoproterenol was administrated from tail vein. At day 7, bone marrow cells
were collected from femoral bones and analyzed.
18F-FDG-PET/CT Examinations
After careful instruction regarding the study and informed consent to partici-
pants, PET/CT examinations of healthy young volunteers (24.8 ± 5.8 years of
age, n = 20) were performed. The protocol was approved by the institutional
review boards of Tenshi College. Standardized uptake value (SUV) was
measured by an expert as described in the Supplemental Experimental
Procedures. Data are reported as means ± SEM. Statistics analyses were
performed using SPSS software, version 18 (International Business Machines
Cell Metabolism
Brown Adipose Production by Hemopoietin CocktailCorp, New York), as described in the Supplemental Experimental Procedures.
P values are considered to be statistically significant if <0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://dx.doi.org/10.1016/j.cmet.2012.08.001.
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